Sanofi Cons. Health Stock Price Analysis and Quick Research Report. Is Sanofi Cons. Health an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Sanofi Cons. Health. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Sanofi Cons. Health has a PE ratio of 34.9216958849646 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Sanofi Cons. Health has ROA of 37.2566% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Sanofi Cons. Health has a Current ratio of 3.8497.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Sanofi Cons. Health has a ROE of 73.2012%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Sanofi Cons. Health has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

• Sales growth: Sanofi Cons. Health has reported revenue growth of 21.2422% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Sanofi Cons. Health for the current financial year is 35.1775956284153%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Sanofi Cons. Health is Rs 75 and the yield is 1.8676%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Sanofi Cons. Health is Rs 115.4984. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Sanofi Cons. Health in Ticker for free. Also, one can get the intrinsic value of Sanofi Cons. Health by using Valuation Calculators, which are available with a Finology ONE subscription. 

Sanofi Cons. Health FAQs

Q1. What is Sanofi Cons. Health share price today?
Ans: The current share price of Sanofi Cons. Health is Rs 4033.4.

Q2. What is the market capitalisation of Sanofi Cons. Health?
Ans: Sanofi Cons. Health has a market capitalisation of Rs 9289.17107748 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Sanofi Cons. Health?
Ans: The PE ratio of Sanofi Cons. Health is 34.9216958849646 and the P/B ratio of Sanofi Cons. Health is 26.6983511282625, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Sanofi Cons. Health share?
Ans: The 52-week high share price of Sanofi Cons. Health is Rs 5255, and the 52-week low share price of Sanofi Cons. Health is Rs 3926.

Q5. Does Sanofi Cons. Health pay dividends?
Ans: Currently, Sanofi Cons. Health pays dividends. Dividend yield of Sanofi Cons. Health is around 1.8676%.

Q6. What are the face value and book value of Sanofi Cons. Health shares?
Ans: The face value of Sanofi Cons. Health shares is Rs 10, while the book value per share of Sanofi Cons. Health is around Rs 151.073. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Sanofi Cons. Health?
Ans: Sanofi Cons. Health has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Sanofi Cons. Health?
Ans: The ROE of Sanofi Cons. Health is 73.2012% and ROCE of Sanofi Cons. Health is 98.1126%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Sanofi Cons. Health a good buy for the long term?
Ans: The Sanofi Cons. Health long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Sanofi Cons. Health undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Sanofi Cons. Health appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Sanofi Cons. Health’s financials?
Ans: You can review Sanofi Cons. Health’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.